Monte Rosa Therapeutics, Inc. (GLUE): Shares Outstanding

Annual figures by period end, from SEC filings.

65.54M
As of 2025-12-31
85.23M
As of 2026-06-30
+9.9%
3-year compound annual growth
+107.9%
5-year compound annual growth
2020-12-31: 1.69M2021-12-31: 46.54M2022-12-31: 49.32M2023-12-31: 50.14M2024-12-31: 61.51M2025-12-31: 65.54M65.54M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3165.54M+6.6%2026-03-17, Balance as of period end
2024-12-3161.51M+22.7%2026-03-17, Balance as of period end
2023-12-3150.14M+1.7%2025-03-20, Balance as of period end
2022-12-3149.32M+6.0%2024-03-14, Balance as of period end
2021-12-3146.54Mn/m2023-03-16, Balance as of period end
2020-12-311.69Mn/a2022-03-29, Balance as of period end